TB-500
| Vendor | Price | 10mg cost | Updated | Actions |
|---|---|---|---|---|
| Peptides For Less 6.5/10 COA ✓Ships: USCredit/debit card Verification & shipping6.5/10 COA ✓Ships: USCredit/debit card | $22.50 | $22.50Checked aug 13, 2026 | Aug 13, 2026 | Buy TB-500 from Peptides For Less |
| Amino Club 10/10 COA ✓Ships: US + internationalVisa · American Express Verification & shipping10/10 COA ✓Ships: US + internationalVisa · American Express | $25.99 | $25.99Checked aug 7, 2026 | Aug 7, 2026 | Buy TB-500 from Amino Club |
| Lost Coast Aminos 9.5/10 COA ✓Ships: USCredit/debit card · Zelle Verification & shipping9.5/10 COA ✓Ships: USCredit/debit card · Zelle | $30.60 | $30.60Checked 6 days ago | 6 days ago | Buy TB-500 from Lost Coast Aminos |
| Alpha Peptides 8/10 COA ✓Ships: USCredit/debit card Verification & shipping8/10 COA ✓Ships: USCredit/debit card | $31.32 | $31.32Checked jul 31, 2026 | Jul 31, 2026 | Buy TB-500 from Alpha Peptides |
| NextGen Peptides 8/10 COA ✓Ships: USVisa · American Express Verification & shipping8/10 COA ✓Ships: USVisa · American Express | $31.50 | $31.50Checked jul 24, 2026 | Jul 24, 2026 | Buy TB-500 from NextGen Peptides |
| Everest Peptides 9/10 COA ✓Ships: US + CanadaCredit/debit card Verification & shipping9/10 COA ✓Ships: US + CanadaCredit/debit card | $31.99 | $31.99Checked jul 28, 2026 | Jul 28, 2026 | Buy TB-500 from Everest Peptides |
Current market data
TB-500 Price Report
A current summary of public listings after the price comparison above. Shipping and tax are not included.
The lowest current whole-package cost to obtain at least 10mg of TB-500 is $25.99 from Amino Club. The median 10mg cost across vendors is $54.78.
- Lowest 10mg cost
- $25.99 Amino Club
- Median 10mg cost
- $54.78 One normalized offer per vendor
- Lowest package total
- $23.99 MsAmino · package size may differ
- Public COA coverage
- 96% 74 of 77 vendors
What the market shows
PeptidePrices found 100 in-stock listings from 77 vendors. The lowest 10mg cost is 53% below the normalized vendor median.
A public COA link shows that a vendor publishes testing data. It does not prove that every listed vial has a matching current report. Match the product, strength, batch, and lot before relying on a report.
How this report is calculated
The headline and median use each vendor's lowest whole-package checkout cost to obtain at least 10mg. Smaller packages are multiplied until the target is met, while larger packages retain their full checkout price. The lowest package total is shown only as secondary context because package sizes differ. Known public coupon discounts are applied. Shipping, tax, and unverified promotions are excluded.
Research details
TB-500 — research data
Overview
About TB-500
Mechanism of action
Upregulates actin, promotes cell migration and proliferation, inhibits inflammatory cytokines (IL-6, TNF-α), stimulates angiogenesis and neurogenesis.
Safety profile
Head rush/fatigue immediately post-injection; possible nausea; theoretical concern re: cancer proliferation (avoid with active malignancy). · Parent protein TB4 has Phase II data; fragment widely used anecdotally; proangiogenic concern theoretical
Storage
Stability & handling
Safety & Interactions
Contraindications & Drug Interactions
Research use only — not medical advice. Consult a licensed physician before using any peptide. Sources are cited where available.
Active malignancy — TB-500 is pro-angiogenic and may theoretically accelerate tumor growth.
Pregnancy and lactation — no human safety data.
Frequently stacked with BPC-157 for tissue repair; no clinical evidence of synergy but widely reported anecdotally.
Research products are not for human use. Looking for clinician-supervised care instead? Compare licensed US telehealth programs that may offer provider-guided peptide protocols when clinically appropriate.
Compare supervised options →Related pages
More on TB-500
Stack & Compare
Frequently Researched Together
Research
Studies & key findings
- Promotes cardiac repair by activating integrin-linked kinase (ILK) in epicardial progenitor cells, mobilizing them to regenerate damaged myocardium after MI.
- Phase 1 RCT in healthy volunteers (2010) confirmed IV thymosin β4 was safe and well-tolerated, clearing a key hurdle for clinical development.